SIMILAR PATTERNS OF AMINO ACIDS FOR 4Q5M_A_ROCA1101_3
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1am5 | PEPSIN (Gadus morhua) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.58A | 4q5mA-1am5A:9.3 | 4q5mA-1am5A:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1b2h | PERIPLASMICOLIGOPEPTIDE-BINDINGPROTEIN (Salmonellaenterica) |
PF00496(SBP_bac_5) | 3 | ASP A 122ASP A 433ASN A 436 | None | 0.78A | 4q5mA-1b2hA:undetectable | 4q5mA-1b2hA:16.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g0v | PROTEINASE A (Saccharomycescerevisiae) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.66A | 4q5mA-1g0vA:9.4 | 4q5mA-1g0vA:23.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1htr | GASTRICSIN (Homo sapiens) |
PF00026(Asp) | 3 | ASP B 217ASP B 32ASN B 37 | None | 0.60A | 4q5mA-1htrB:8.3 | 4q5mA-1htrB:23.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1i74 | PROBABLEMANGANESE-DEPENDENTINORGANICPYROPHOSPHATASE (Streptococcusmutans) |
PF01368(DHH)PF02833(DHHA2) | 3 | ASP A 149ASP A 75ASN A 77 | MN A 402 ( 2.6A) MN A 401 (-2.5A)None | 0.84A | 4q5mA-1i74A:undetectable | 4q5mA-1i74A:20.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nrw | HYPOTHETICALPROTEIN, HALOACIDDEHALOGENASE-LIKEHYDROLASE (Bacillussubtilis) |
PF08282(Hydrolase_3) | 3 | ASP A 237ASP A 7ASN A 65 | CA A 903 (-2.9A)PO4 A 900 ( 2.6A)None | 0.82A | 4q5mA-1nrwA:undetectable | 4q5mA-1nrwA:21.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1o4z | BETA-AGARASE B (Zobelliagalactanivorans) |
PF00722(Glyco_hydro_16) | 3 | ASP A 102ASP A 103ASN A 92 | None | 0.81A | 4q5mA-1o4zA:undetectable | 4q5mA-1o4zA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1p8r | ARGINASE 1 (Rattusnorvegicus) |
PF00491(Arginase) | 3 | ASP A 124ASP A 128ASN A 139 | MN A 500 (-2.6A) MN A 501 ( 2.6A)None | 0.81A | 4q5mA-1p8rA:undetectable | 4q5mA-1p8rA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q0p | COMPLEMENT FACTOR B (Homo sapiens) |
PF00092(VWA) | 3 | ASP A 364ASP A 251ASN A 329 | MN A 500 ( 4.0A) MN A 500 ( 4.0A)None | 0.66A | 4q5mA-1q0pA:undetectable | 4q5mA-1q0pA:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qdm | PROPHYTEPSIN (Hordeum vulgare) |
PF00026(Asp)PF03489(SapB_2)PF05184(SapB_1) | 3 | ASP A 223ASP A 36ASN A 41 | None | 0.59A | 4q5mA-1qdmA:9.3 | 4q5mA-1qdmA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qrp | PEPSIN 3A (Homo sapiens) |
PF00026(Asp) | 3 | ASP E 215ASP E 32ASN E 37 | HH0 E 327 (-2.5A)HH0 E 327 (-2.7A)None | 0.52A | 4q5mA-1qrpE:10.2 | 4q5mA-1qrpE:24.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qs8 | PLASMEPSIN (Plasmodiumvivax) |
PF00026(Asp) | 3 | ASP A 214ASP A 34ASN A 39 | None | 0.53A | 4q5mA-1qs8A:9.9 | 4q5mA-1qs8A:22.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rtk | COMPLEMENT FACTOR B (Homo sapiens) |
PF00089(Trypsin)PF00092(VWA) | 3 | ASP A 364ASP A 251ASN A 329 | MG A 749 ( 4.4A) MG A 749 ( 4.3A)None | 0.66A | 4q5mA-1rtkA:undetectable | 4q5mA-1rtkA:15.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1smr | RENIN (Mus musculus) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.71A | 4q5mA-1smrA:5.3 | 4q5mA-1smrA:22.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1t0p | INTEGRIN ALPHA-L (Homo sapiens) |
PF00092(VWA) | 3 | ASP A 239ASP A 137ASN A 207 | MG A 901 ( 3.9A) MG A 901 ( 4.0A)None | 0.83A | 4q5mA-1t0pA:undetectable | 4q5mA-1t0pA:19.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1toz | NEUROGENIC LOCUSNOTCH HOMOLOGPROTEIN 1 (Homo sapiens) |
PF00008(EGF)PF07645(EGF_CA) | 3 | ASP A 452ASP A 469ASN A 459 | None | 0.56A | 4q5mA-1tozA:undetectable | 4q5mA-1tozA:19.02 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tzs | CATHEPSIN E (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 228ASP A 43ASN A 48 | None | 0.61A | 4q5mA-1tzsA:10.0 | 4q5mA-1tzsA:22.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1wkr | POLYPOROPEPSIN (Irpex lacteus) |
PF00026(Asp) | 3 | ASP A 212ASP A 32ASN A 37 | None | 0.55A | 4q5mA-1wkrA:9.8 | 4q5mA-1wkrA:20.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y75 | PHOSPHOLIPASE A2ISOFORM 5PHOSPHOLIPASE A2ISOFORM 6 (Najasagittifera) |
PF00068(Phospholip_A2_1) | 3 | ASP A 24ASP B 24ASN B 110 | ZN A 401 (-2.1A) ZN A 401 (-2.1A)None | 0.56A | 4q5mA-1y75A:undetectable | 4q5mA-1y75A:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y75 | PHOSPHOLIPASE A2ISOFORM 5PHOSPHOLIPASE A2ISOFORM 6 (Najasagittifera) |
PF00068(Phospholip_A2_1) | 3 | ASP B 24ASP A 24ASN A 110 | ZN A 401 (-2.1A) ZN A 401 (-2.1A)None | 0.60A | 4q5mA-1y75B:undetectable | 4q5mA-1y75B:16.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2anl | PLASMEPSIN IV (Plasmodiummalariae) |
PF00026(Asp) | 3 | ASP A 214ASP A 34ASN A 39 | JE2 A3151 (-2.5A)JE2 A3151 (-3.0A)None | 0.65A | 4q5mA-2anlA:9.6 | 4q5mA-2anlA:22.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bju | PLASMEPSIN II (Plasmodiumfalciparum) |
PF00026(Asp) | 3 | ASP A 214ASP A 34ASN A 39 | IH4 A1330 (-3.3A)IH4 A1330 (-4.2A)None | 0.84A | 4q5mA-2bjuA:8.9 | 4q5mA-2bjuA:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bws | XAA-PROAMINOPEPTIDASE P (Escherichiacoli) |
PF00557(Peptidase_M24)PF05195(AMP_N) | 3 | ASP A 271ASP A 260ASN A 230 | MN A1442 ( 2.4A) MN A1442 (-2.0A)None | 0.84A | 4q5mA-2bwsA:undetectable | 4q5mA-2bwsA:19.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2cev | PROTEIN (ARGINASE) ([Bacillus]caldovelox) |
PF00491(Arginase) | 3 | ASP A 122ASP A 126ASN A 137 | MN A 302 (-2.5A) MN A 301 ( 2.6A)None | 0.74A | 4q5mA-2cevA:undetectable | 4q5mA-2cevA:23.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dg0 | DRP35 (Staphylococcusaureus) |
PF08450(SGL) | 3 | ASP A 236ASP A 138ASN A 88 | None | 0.79A | 4q5mA-2dg0A:undetectable | 4q5mA-2dg0A:22.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ef4 | ARGINASE (Thermusthermophilus) |
PF00491(Arginase) | 3 | ASP A 119ASP A 123ASN A 134 | None | 0.76A | 4q5mA-2ef4A:undetectable | 4q5mA-2ef4A:20.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ewy | BETA-SECRETASE 2 (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 241ASP A 48ASN A 53 | DBO A1001 (-3.2A)DBO A1001 (-2.7A)None | 0.61A | 4q5mA-2ewyA:9.2 | 4q5mA-2ewyA:23.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g1s | RENIN (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 221ASP A 33ASN A 38 | 4IG A 885 (-2.6A)4IG A 885 (-2.7A)None | 0.60A | 4q5mA-2g1sA:10.6 | 4q5mA-2g1sA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2i34 | ACID PHOSPHATASE (Bacillusanthracis) |
PF03767(Acid_phosphat_B) | 3 | ASP A 184ASP A 180ASN A 73 | MG A 301 ( 4.2A) MG A 301 (-2.5A)None | 0.71A | 4q5mA-2i34A:undetectable | 4q5mA-2i34A:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2l1w | CALMODULIN (Glycine max) |
PF13499(EF-hand_7) | 3 | ASP A 95ASP A 93ASN A 137 | CA A 221 (-2.3A) CA A 221 (-3.5A) CA A 234 (-3.6A) | 0.83A | 4q5mA-2l1wA:undetectable | 4q5mA-2l1wA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2mte | CELLULOSE1,4-BETA-CELLOBIOSIDASE (REDUCING END)CELS (Ruminiclostridiumthermocellum) |
PF00404(Dockerin_1) | 3 | ASP A 43ASP A 50ASN A 37 | CA A 102 (-2.1A) CA A 102 (-1.9A)None | 0.60A | 4q5mA-2mteA:undetectable | 4q5mA-2mteA:17.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2odp | COMPLEMENT C2 (Homo sapiens) |
PF00089(Trypsin)PF00092(VWA) | 3 | ASP A 356ASP A 240ASN A 318 | MG A 901 ( 4.0A) MG A 901 ( 3.9A)None | 0.72A | 4q5mA-2odpA:undetectable | 4q5mA-2odpA:18.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2rhp | THROMBOSPONDIN-2 (Homo sapiens) |
PF02412(TSP_3)PF05735(TSP_C)PF07645(EGF_CA)PF12947(EGF_3) | 3 | ASP A 718ASP A 696ASN A1017 | CA A 29 ( 2.3A) CA A 28 ( 2.6A)None | 0.70A | 4q5mA-2rhpA:undetectable | 4q5mA-2rhpA:15.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vdw | VACCINIA VIRUSCAPPING ENZYME D1SUBUNIT (Vaccinia virus) |
PF03291(Pox_MCEL) | 3 | ASP A 676ASP A 604ASN A 601 | SAH A1846 ( 4.7A)SAH A1846 ( 4.5A)SO4 A1845 (-4.1A) | 0.83A | 4q5mA-2vdwA:undetectable | 4q5mA-2vdwA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2we9 | MOBA-RELATED PROTEIN (Mycobacteriumtuberculosis) |
PF12804(NTP_transf_3) | 3 | ASP A 105ASP A 183ASN A 17 | GOL A1196 (-3.4A)NoneNone | 0.84A | 4q5mA-2we9A:undetectable | 4q5mA-2we9A:23.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xwb | COMPLEMENT FACTOR B (Homo sapiens) |
PF00084(Sushi)PF00089(Trypsin)PF00092(VWA) | 3 | ASP F 364ASP F 251ASN F 329 | MG F1742 ( 4.2A) MG F1742 ( 4.5A)None | 0.83A | 4q5mA-2xwbF:undetectable | 4q5mA-2xwbF:13.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ak5 | HEMOGLOBIN-BINDINGPROTEASE HBP (Escherichiacoli) |
PF02395(Peptidase_S6) | 3 | ASP A 744ASP A 639ASN A 717 | None | 0.85A | 4q5mA-3ak5A:undetectable | 4q5mA-3ak5A:12.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bij | UNCHARACTERIZEDPROTEIN GSU0716 (Geobactersulfurreducens) |
PF00656(Peptidase_C14) | 3 | ASP A 133ASP A 32ASN A 27 | None | 0.84A | 4q5mA-3bijA:undetectable | 4q5mA-3bijA:20.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3et5 | OUTER MEMBRANEPROTEIN P4, NADPPHOSPHATASE (Haemophilusinfluenzae) |
PF03767(Acid_phosphat_B) | 3 | ASP A 185ASP A 181ASN A 72 | MG A 255 ( 4.2A) MG A 255 (-2.6A)None | 0.73A | 4q5mA-3et5A:undetectable | 4q5mA-3et5A:20.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ewe | NUCLEOPORIN NUP85 (Saccharomycescerevisiae) |
PF07575(Nucleopor_Nup85) | 3 | ASP B 330ASP B 334ASN B 342 | None | 0.79A | 4q5mA-3eweB:undetectable | 4q5mA-3eweB:17.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fby | CARTILAGE OLIGOMERICMATRIX PROTEIN (Homo sapiens) |
PF02412(TSP_3)PF05735(TSP_C) | 3 | ASP A 290ASP A 271ASN A 589 | CA A 802 ( 2.3A) CA A 801 ( 2.8A)None | 0.75A | 4q5mA-3fbyA:undetectable | 4q5mA-3fbyA:15.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hig | AMILORIDE-SENSITIVEAMINE OXIDASE (Homo sapiens) |
PF01179(Cu_amine_oxid)PF02727(Cu_amine_oxidN2)PF02728(Cu_amine_oxidN3) | 3 | ASP A 664ASP A 519ASN A 338 | CA A 802 (-3.2A) CA A 802 (-3.2A)None | 0.56A | 4q5mA-3higA:undetectable | 4q5mA-3higA:13.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3igz | COFACTOR-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Leishmaniamexicana) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 3 | ASP B 23ASP B 466ASN B 80 | CO B 563 ( 2.2A) CO B 563 (-2.4A)None | 0.80A | 4q5mA-3igzB:undetectable | 4q5mA-3igzB:17.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3jte | RESPONSE REGULATORRECEIVER PROTEIN (Ruminiclostridiumthermocellum) |
PF00072(Response_reg) | 3 | ASP A 11ASP A 10ASN A 18 | None | 0.85A | 4q5mA-3jteA:undetectable | 4q5mA-3jteA:23.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nvl | 2,3-BISPHOSPHOGLYCERATE-INDEPENDENTPHOSPHOGLYCERATEMUTASE (Trypanosomabrucei) |
PF01676(Metalloenzyme)PF06415(iPGM_N) | 3 | ASP A 22ASP A 465ASN A 79 | CO A 553 (-2.1A) CO A 553 (-2.3A)None | 0.76A | 4q5mA-3nvlA:undetectable | 4q5mA-3nvlA:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pct | CLASS C ACIDPHOSPHATASE (Pasteurellamultocida) |
PF03767(Acid_phosphat_B) | 3 | ASP A 184ASP A 180ASN A 71 | None | 0.71A | 4q5mA-3pctA:undetectable | 4q5mA-3pctA:18.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3psg | PEPSINOGEN (Sus scrofa) |
PF00026(Asp)PF07966(A1_Propeptide) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.68A | 4q5mA-3psgA:8.5 | 4q5mA-3psgA:20.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q2w | CADHERIN-2 (Mus musculus) |
PF00028(Cadherin) | 3 | ASP A 331ASP A 366ASN A 335 | CA A 608 (-3.2A) CA A 608 ( 3.4A)None | 0.75A | 4q5mA-3q2wA:undetectable | 4q5mA-3q2wA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q5i | PROTEIN KINASE (Plasmodiumberghei) |
PF00069(Pkinase)PF13499(EF-hand_7) | 3 | ASP A 502ASP A 498ASN A 491 | CA A 526 (-2.9A) CA A 526 (-3.1A)None | 0.82A | 4q5mA-3q5iA:undetectable | 4q5mA-3q5iA:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qc5 | PLATELET BINDINGPROTEIN GSPB (Streptococcusgordonii) |
no annotation | 3 | ASP X 399ASP X 427ASN X 496 | K X 1 (-2.1A) K X 1 ( 2.0A)None | 0.82A | 4q5mA-3qc5X:undetectable | 4q5mA-3qc5X:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qs1 | PLASMEPSIN-1 (Plasmodiumfalciparum) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | 006 A 330 (-2.8A)006 A 330 (-2.8A)None | 0.71A | 4q5mA-3qs1A:10.0 | 4q5mA-3qs1A:22.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sl1 | ARGINASE (Plasmodiumfalciparum) |
PF00491(Arginase) | 3 | ASP A 216ASP A 220ASN A 231 | MN A 413 (-2.6A)FB6 A 414 ( 2.6A)None | 0.83A | 4q5mA-3sl1A:undetectable | 4q5mA-3sl1A:17.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ti7 | BASIC EXTRACELLULARSUBTILISIN-LIKEPROTEASE BPRV (Dichelobacternodosus) |
PF00082(Peptidase_S8) | 3 | ASP A 74ASP A 69ASN A 66 | CA A 354 ( 2.4A) CA A 355 ( 2.3A)None | 0.83A | 4q5mA-3ti7A:undetectable | 4q5mA-3ti7A:21.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w57 | C2 DOMAIN PROTEIN (Scophthalmusmaximus) |
PF00168(C2) | 3 | ASP A 35ASP A 88ASN A 59 | CA A 201 ( 2.9A) CA A 201 ( 2.3A)None | 0.85A | 4q5mA-3w57A:undetectable | 4q5mA-3w57A:21.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4amt | RENIN (Homo sapiens) |
PF00026(Asp)PF07966(A1_Propeptide) | 3 | ASP A 269ASP A 81ASN A 86 | None | 0.59A | 4q5mA-4amtA:6.6 | 4q5mA-4amtA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4cyf | PANTETHEINASE (Homo sapiens) |
PF00795(CN_hydrolase) | 3 | ASP A 98ASP A 141ASN A 189 | None | 0.71A | 4q5mA-4cyfA:undetectable | 4q5mA-4cyfA:17.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dh2 | CELLULOSOMEANCHORING PROTEINCOHESIN REGIONDOCKERIN TYPE 1 (Ruminiclostridiumthermocellum) |
PF00404(Dockerin_1)PF00963(Cohesin) | 3 | ASP B 9ASP B 20ASN A 140 | CA B 101 (-3.3A) CA B 101 (-2.1A)None | 0.74A | 4q5mA-4dh2B:undetectable | 4q5mA-4dh2B:18.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dni | FUSION PROTEIN OFRNA-EDITING COMPLEXPROTEINS MP42 ANDMP18 (Trypanosomabrucei) |
PF00436(SSB) | 3 | ASP A 82ASP A 84ASN A 161 | None | 0.77A | 4q5mA-4dniA:undetectable | 4q5mA-4dniA:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ehc | PE-PGRS FAMILYPROTEIN (Mycobacteriumtuberculosis) |
no annotation | 3 | ASP A 36ASP A 189ASN A 194 | ZN A 301 (-2.3A) ZN A 301 (-2.0A)EDO A 320 (-3.1A) | 0.79A | 4q5mA-4ehcA:11.2 | 4q5mA-4ehcA:22.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g9i | HYDROGENASEMATURATION PROTEINHYPF (Thermococcuskodakarensis) |
PF00708(Acylphosphatase)PF00814(Peptidase_M22)PF01300(Sua5_yciO_yrdC)PF07503(zf-HYPF) | 3 | ASP A 509ASP A 746ASN A 427 | ZN A1003 (-2.2A) ZN A1003 (-2.4A)None | 0.74A | 4q5mA-4g9iA:undetectable | 4q5mA-4g9iA:13.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h3w | HYPOTHETICAL PROTEIN (Parabacteroidesdistasonis) |
PF15414(DUF4621) | 3 | ASP A 90ASP A 200ASN A 206 | MLY A 91 ( 4.2A)MLY A 202 ( 4.0A)MLY A 202 ( 3.4A) | 0.77A | 4q5mA-4h3wA:undetectable | 4q5mA-4h3wA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxq | ARGINASE-1 (Homo sapiens) |
PF00491(Arginase) | 3 | ASP A 124ASP A 128ASN A 139 | MN A 903 (-2.5A) MN A 903 ( 2.6A)None | 0.75A | 4q5mA-4hxqA:undetectable | 4q5mA-4hxqA:24.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iu4 | ARGINASE (Leishmaniamexicana) |
PF00491(Arginase) | 3 | ASP A 137ASP A 141ASN A 152 | MN A 401 (-2.6A) MN A 401 ( 2.5A)None | 0.75A | 4q5mA-4iu4A:undetectable | 4q5mA-4iu4A:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ixu | ARGINASE-2,MITOCHONDRIAL (Homo sapiens) |
PF00491(Arginase) | 3 | ASP A 143ASP A 147ASN A 158 | MN A 401 (-2.5A)38I A 406 ( 2.5A)None | 0.82A | 4q5mA-4ixuA:undetectable | 4q5mA-4ixuA:19.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jo0 | CMLA (Streptomycesvenezuelae) |
PF12706(Lactamase_B_2) | 3 | ASP A 309ASP A 403ASN A 459 | FE A 602 (-2.2A) FE A 602 ( 2.6A)None | 0.81A | 4q5mA-4jo0A:undetectable | 4q5mA-4jo0A:16.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4pv4 | PROLINEAMINOPEPTIDASE P II (Yersinia pestis) |
PF00557(Peptidase_M24)PF05195(AMP_N) | 3 | ASP A 269ASP A 258ASN A 228 | MG A 501 ( 2.5A) MG A 501 ( 2.0A)None | 0.80A | 4q5mA-4pv4A:undetectable | 4q5mA-4pv4A:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q3r | ARGINASE (Schistosomamansoni) |
PF00491(Arginase) | 3 | ASP A 154ASP A 158ASN A 169 | MN A 401 (-2.6A) MN A 401 ( 2.5A)None | 0.76A | 4q5mA-4q3rA:undetectable | 4q5mA-4q3rA:22.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rcd | BETA-SECRETASE 1 (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 32ASP A 228ASN A 233 | 3LL A 501 (-2.8A)3LL A 501 (-2.6A)None | 0.57A | 4q5mA-4rcdA:9.3 | 4q5mA-4rcdA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rcd | BETA-SECRETASE 1 (Homo sapiens) |
PF00026(Asp) | 3 | ASP A 228ASP A 32ASN A 37 | 3LL A 501 (-2.6A)3LL A 501 (-2.8A)None | 0.62A | 4q5mA-4rcdA:9.3 | 4q5mA-4rcdA:19.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rn7 | N-ACETYLMURAMOYL-L-ALANINE AMIDASE (Clostridioidesdifficile) |
PF01520(Amidase_3) | 3 | ASP A 143ASP A 171ASN A 128 | None | 0.75A | 4q5mA-4rn7A:undetectable | 4q5mA-4rn7A:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rpa | PROBABLEMANGANESE-DEPENDENTINORGANICPYROPHOSPHATASE (Staphylococcusaureus) |
PF01368(DHH)PF02833(DHHA2) | 3 | ASP A 149ASP A 75ASN A 77 | MN A 500 (-2.6A) MN A 500 ( 2.4A)None | 0.82A | 4q5mA-4rpaA:undetectable | 4q5mA-4rpaA:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uaq | PROTEIN TRANSLOCASESUBUNIT SECA 2 (Mycobacteriumtuberculosis) |
PF01043(SecA_PP_bind)PF07516(SecA_SW)PF07517(SecA_DEAD) | 3 | ASP A 224ASP A 219ASN A 540 | None | 0.80A | 4q5mA-4uaqA:undetectable | 4q5mA-4uaqA:13.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj5 | CYCLIC AMP-GMPSYNTHASE (Vibrio cholerae) |
no annotation | 3 | ASP A 133ASP A 131ASN A 121 | MG A1001 ( 2.7A) MG A1002 (-2.0A)None | 0.84A | 4q5mA-4xj5A:undetectable | 4q5mA-4xj5A:19.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xj6 | VC0179-LIKE PROTEIN (Escherichiacoli) |
no annotation | 3 | ASP A 131ASP A 129ASN A 119 | MG A 501 ( 2.5A) MG A 502 (-2.2A)None | 0.72A | 4q5mA-4xj6A:undetectable | 4q5mA-4xj6A:16.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xru | PNKP1 (Capnocytophagagingivalis) |
PF13671(AAA_33) | 3 | ASP A 288ASP A 287ASN A 265 | MG A 401 (-2.2A) MG A 401 ( 4.8A)None | 0.80A | 4q5mA-4xruA:undetectable | 4q5mA-4xruA:19.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4yg8 | CHITIN BIOSYNTHESISPROTEIN CHS6 (Saccharomycescerevisiae) |
PF09295(ChAPs) | 3 | ASP B 588ASP B 592ASN B 510 | None | 0.76A | 4q5mA-4yg8B:undetectable | 4q5mA-4yg8B:14.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zng | PROLIDASE (Lactococcuslactis) |
no annotation | 3 | ASP C 221ASP C 232ASN C 324 | MN C 401 (-2.2A) MN C 401 (-2.2A)None | 0.83A | 4q5mA-4zngC:undetectable | 4q5mA-4zngC:19.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cde | PROLINE DIPEPTIDASE (Xanthomonascampestris) |
PF00557(Peptidase_M24)PF01321(Creatinase_N) | 3 | ASP A 251ASP A 262ASN A 359 | ZN A 402 (-2.0A) ZN A 402 ( 2.3A)None | 0.82A | 4q5mA-5cdeA:undetectable | 4q5mA-5cdeA:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5eyy | CENTROLOBIUMTOMENTOSUM LECTIN (Centrolobiumtomentosum) |
PF00139(Lectin_legB) | 3 | ASP A 131ASP A 142ASN A 137 | CA A 302 ( 2.1A) MN A 303 ( 2.7A)MDM A 304 (-2.9A) | 0.83A | 4q5mA-5eyyA:undetectable | 4q5mA-5eyyA:18.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foe | GDP-FUCOSE PROTEINO-FUCOSYLTRANSFERASE2,THROMBOSPONDIN-1 (Caenorhabditiselegans;Homo sapiens) |
PF00090(TSP_1)PF10250(O-FucT) | 3 | ASP A 259ASP A 248ASN A 241 | None | 0.54A | 4q5mA-5foeA:undetectable | 4q5mA-5foeA:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fqe | BETA-N-ACETYLGALACTOSAMINIDASE (Clostridiumperfringens) |
PF13320(DUF4091) | 3 | ASP A 42ASP A 512ASN A 570 | NoneNone BR A1632 (-4.8A) | 0.85A | 4q5mA-5fqeA:undetectable | 4q5mA-5fqeA:15.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hj2 | INTEGRIN ALPHA-2 (Homo sapiens) |
no annotation | 3 | ASP C 118ASP C 15ASN C 86 | CA C 301 (-3.4A) CA C 301 ( 4.5A)None | 0.74A | 4q5mA-5hj2C:undetectable | 4q5mA-5hj2C:22.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5i70 | PLASMEPSIN IV (Plasmodiumfalciparum) |
no annotation | 3 | ASP B 214ASP B 34ASN B 39 | None | 0.47A | 4q5mA-5i70B:10.1 | 4q5mA-5i70B:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jqk | PEPTIDASE, PUTATIVE (Plasmodiumfalciparum) |
PF00557(Peptidase_M24)PF01321(Creatinase_N)PF16188(Peptidase_M24_C)PF16189(Creatinase_N_2) | 3 | ASP A 570ASP A 581ASN A 675 | MN A 802 ( 1.9A) MN A 802 (-2.2A)None | 0.69A | 4q5mA-5jqkA:undetectable | 4q5mA-5jqkA:15.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ksd | ATPASE 2, PLASMAMEMBRANE-TYPE (Arabidopsisthaliana) |
PF00122(E1-E2_ATPase)PF00690(Cation_ATPase_N)PF00702(Hydrolase) | 3 | ASP A 275ASP A 92ASN A 85 | None | 0.74A | 4q5mA-5ksdA:undetectable | 4q5mA-5ksdA:14.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mkt | RENIN-1 (Mus musculus) |
no annotation | 3 | ASP A 266ASP A 81ASN A 86 | None | 0.80A | 4q5mA-5mktA:9.1 | 4q5mA-5mktA:19.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5mlg | RENIN (Rattusnorvegicus) |
no annotation | 3 | ASP A 266ASP A 81ASN A 86 | None | 0.66A | 4q5mA-5mlgA:9.9 | 4q5mA-5mlgA:18.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5n7q | PUTATIVE CATHEPSIN D (Ixodes ricinus) |
no annotation | 3 | ASP A 227ASP A 36ASN A 41 | None | 0.55A | 4q5mA-5n7qA:10.0 | 4q5mA-5n7qA:17.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5pep | PEPSIN (Sus scrofa) |
PF00026(Asp) | 3 | ASP A 215ASP A 32ASN A 37 | None | 0.51A | 4q5mA-5pepA:9.7 | 4q5mA-5pepA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5t4m | PROTOCADHERIN-15 (Homo sapiens) |
PF00028(Cadherin) | 3 | ASP A 516ASP A 514ASN A 575 | CA A 704 ( 3.3A) CA A 705 (-2.1A)None | 0.84A | 4q5mA-5t4mA:undetectable | 4q5mA-5t4mA:21.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5u1c | HIV-1 INTEGRASE,SSO7D CHIMERA (Humanimmunodeficiencyvirus 1;Sulfolobussolfataricus) |
PF00552(IN_DBD_C)PF00665(rve)PF02022(Integrase_Zn) | 3 | ASP A 64ASP A 116ASN A 144 | MG A 501 (-1.8A) MG A 501 (-2.8A)None | 0.68A | 4q5mA-5u1cA:undetectable | 4q5mA-5u1cA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5udy | ECTONUCLEOTIDEPYROPHOSPHATASE/PHOSPHODIESTERASE FAMILYMEMBER 7 (Homo sapiens) |
PF01663(Phosphodiest) | 3 | ASP A 187ASP A 189ASN A 31 | None | 0.68A | 4q5mA-5udyA:undetectable | 4q5mA-5udyA:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ux4 | CATHEPSIN D (Rattusnorvegicus) |
no annotation | 3 | ASP A 226ASP A 33ASN A 38 | 3UT A 404 (-2.4A)3UT A 404 (-2.9A)None | 0.57A | 4q5mA-5ux4A:9.9 | 4q5mA-5ux4A:16.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8f | ORIGIN RECOGNITIONCOMPLEX SUBUNIT 2ORIGIN RECOGNITIONCOMPLEX SUBUNIT 3ORIGIN RECOGNITIONCOMPLEX SUBUNIT 5 (Saccharomycescerevisiae) |
PF04084(ORC2)PF13401(AAA_22)PF14630(ORC5_C)no annotation | 3 | ASP C 111ASP B 466ASN E 423 | None | 0.65A | 4q5mA-5v8fC:undetectable | 4q5mA-5v8fC:16.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wkh | T-CELL RECEPTORALPHA VARIABLE30,T-CELL RECEPTOR,SP3.4 ALPHA CHAIN (Homo sapiens) |
PF07686(V-set)PF09291(DUF1968) | 3 | ASP D 163ASP D 161ASN D 197 | None | 0.73A | 4q5mA-5wkhD:undetectable | 4q5mA-5wkhD:18.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wtl | OMPA FAMILY PROTEIN (Capnocytophagagingivalis) |
no annotation | 3 | ASP A 281ASP A 283ASN A 301 | CA A1008 ( 2.8A) CA A1007 ( 2.7A)None | 0.77A | 4q5mA-5wtlA:undetectable | 4q5mA-5wtlA:15.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wtl | OMPA FAMILY PROTEIN (Capnocytophagagingivalis) |
no annotation | 3 | ASP A 310ASP A 312ASN A 330 | CA A1009 ( 2.8A) CA A1009 ( 2.7A)None | 0.69A | 4q5mA-5wtlA:undetectable | 4q5mA-5wtlA:15.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bm8 | ENVELOPEGLYCOPROTEIN B (Humanalphaherpesvirus1) |
no annotation | 3 | ASP A 608ASP A 579ASN A 112 | None | 0.76A | 4q5mA-6bm8A:undetectable | 4q5mA-6bm8A:16.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ej2 | BETA-SECRETASE 1 (Homo sapiens) |
no annotation | 3 | ASP A 441ASP A 637ASN A 642 | B7E A 901 (-2.9A)B7E A 901 (-2.6A)None | 0.63A | 4q5mA-6ej2A:9.1 | 4q5mA-6ej2A:21.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6ej2 | BETA-SECRETASE 1 (Homo sapiens) |
no annotation | 3 | ASP A 637ASP A 441ASN A 446 | B7E A 901 (-2.6A)B7E A 901 (-2.9A)B7E A 901 (-4.2A) | 0.50A | 4q5mA-6ej2A:9.1 | 4q5mA-6ej2A:21.20 |